All In Biotech

Drug Trial Radar · NCT06752356

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Double-blind, Randomized, Multi-Center Study Investigating Efficacy and Safety of Two Different Dosages of Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 161 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

161

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Dec 20, 2027

Study completion Dec 27, 2027

Sponsor

Lead sponsor
Kedrion S.p.A.Industry
Sponsor type
Industry
First posted
Dec 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The current study is being conducted to assess the efficacy and safety of KIg10 (Intravenous Human Immune globulin 10%) at two different dosages as maintenance therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) following 21 weeks of treatment.

Conditions

  • Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

  • Immune globulin (human) 10% solution for intravenous administrationBiological

    Kedrion intravenous immunoglobulin (IVIg) 10%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of 1.0 g/kg KIg10 in the treatment of adult subjects with active CIDPTime frame: From Baseline upto 24 weeks of treatment

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • New England Institute for Clinical Research

    Stamford, Connecticut · Recruiting

  • Quantix Research

    Miami, Florida · Recruiting

  • Best Choice Medical and Research Service

    Pembroke Pines, Florida · Recruiting

  • USF Health - Morsani Center for Advanced Healthcare

    Tampa, Florida · Recruiting

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Recruiting

  • Advanced Neurology Epilepsy and Sleep Center/ANESC Research

    El Paso, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.